Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
MEDIF MEDIPHARM LABS CORP
0.055
+0.001+1.85%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Assets
Current assets
Cash, cash equivalents and short term investments
-43.25% 21.99M -- 28.27M 71.3% 34.11M -- 34.11M
-Cash and cash equivalents
-43.25% 21.99M -- 28.27M 71.3% 34.11M -- 34.11M
Receivables
-59.91% 14.79M -- 14.86M -50.25% 17.35M -- 17.35M
-Accounts receivable
-50.88% 13.49M -- 13.35M -43.68% 15.32M -- 15.32M
-Taxes receivable
-88.96% 482K -- 400K -97.43% 120K -- 120K
-Other receivables
-83.83% 818K -- 1.11M -36.39% 1.92M -- 1.92M
Inventory
-0.71% 13.56M -- 11.89M -50.42% 10.98M -- 10.98M
Prepaid assets
-- 3.09M -- -- -11.68% 2.2M -- 2.2M
Other current assets
-- -- -31.07% 2.35M -- -- -- --
Total current assets
-42.24% 54.31M -- 58.3M -19.59% 65.55M -- 65.55M
Non current assets
Net PPE
-22.54% 24.47M -- 25.36M -24.28% 25.89M -- 25.89M
-Gross PPE
1.37% 50.72M -- 51.64M 1.88% 51.32M -- 51.32M
-Accumulated depreciation
-42.3% -26.26M -- -26.28M -57.17% -25.43M -- -25.43M
Goodwill and other intangible assets
-82.63% 41K -- 43K -80.7% 44K -- 44K
-Other intangible assets
-82.63% 41K -- 43K -80.7% 44K -- 44K
Investments and advances
-- -- -- -- -- 0 -- 0
Non current accounts receivable
-- 123K -- 123K -- 123K -- 123K
Non current prepaid assets
-86.03% 300K -- 750K -64.93% 753K -- 753K
Total non current assets
-27.02% 24.93M -- 26.28M -26.96% 26.81M -- 26.81M
Total assets
-38.18% 79.24M -- 84.58M -21.88% 92.36M -- 92.36M
Liabilities
Current liabilities
Payables
-46.02% 3.9M -- 2.95M -47.63% 3.3M -- 3.3M
-accounts payable
-46.91% 3.52M -- 2.8M -46.1% 2.99M -- 2.99M
-Due to related parties current
-- -- -- -- -- 0 -- 0
-Other payable
-- 383K -- 156K -31.63% 307K -- 307K
Current accrued expenses
-77.19% 1.2M -- 1.71M -79.5% 1.6M -- 1.6M
Current debt and capital lease obligation
-31.51% 1.37M -98.96% 69K -98.53% 113K -- 113K
-Current debt
-25.46% 1.29M -- -- -- -- -- --
-Current capital lease obligation
-69.71% 83K -- 69K -64.91% 113K -- 113K
Current deferred liabilities
0.33% 1.5M -- 1.53M 31.7% 1.32M -- 1.32M
Current liabilities
-43.54% 10.38M -- 8.1M -63.39% 8.88M -- 8.88M
Non current liabilities
Long term debt and capital lease obligation
-23.91% 70K 1403.96% 87K -99.04% 103K -- 103K
-Long term capital lease obligation
-23.91% 70K -- 87K -52.97% 103K -- 103K
Non current deferred liabilities
-- 221K -95.75% 233K -- 233K -- 233K
Due to related parties non current
-- -- -- -- -- 0 -- 0
Derivative product liabilities
-- 0 -- 1K -99.96% 2K -- 2K
Total non current liabilities
9.4% 291K -- 321K -97.83% 338K -- 338K
Total liabilities
-42.79% 10.67M -- 8.43M -76.86% 9.22M -- 9.22M
Shareholders'equity
Share capital
1.18% 190.84M -- 190.63M 37.57% 190.55M -- 190.55M
-common stock
1.18% 190.84M 286797.85% 190.63M 37.57% 190.55M -- 190.55M
Retained earnings
-45.46% -145.79M -- -136.8M -73.52% -129.34M -- -129.34M
Gains losses not affecting retained earnings
11.23% 23.51M 975.18% 22.32M 51.85% 21.94M -- 21.94M
Total stockholders'equity
-37.4% 68.57M -- 76.16M 6.03% 83.15M -- 83.15M
Total equity
-37.4% 68.57M -- 76.16M 6.03% 83.15M -- 83.15M
Currency Unit
CADCADCADCAD
Audit Opinions
----Unqualified Opinion--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
CEO: Mr. David Pidduck
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...